Apellis Pharmaceuticals, Inc. (APLS)
41.03
0.00 (0.00%)
USD |
NASDAQ |
May 20, 16:00
Apellis Pharmaceuticals Accounts Payable (Quarterly) : 49.05M for March 31, 2026
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Biogen, Inc. | 358.50M |
| Eli Lilly & Co. | 5.029B |
| Agios Pharmaceuticals, Inc. | 13.75M |
| Spyre Therapeutics, Inc. | 5.692M |
| Scholar Rock Holding Corp. | 9.218M |